AMN vs JAZZ · rev $2.98B vs P/E 1988, rev $4.07B
AMN Healthcare Services Inc (AMN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
AMN Healthcare Services Inc (AMN) is a medical care facilities company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported AMN revenue for 2024-12-31 was $2.98B. Net income was -$147.0M. Revenue was down 21.3% from 2023-12-31 to 2024-12-31. AMN currently screens at market cap $1.23B.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
AMN currently screens at market cap $1.23B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the AMN and JAZZ stock pages for the full models.
Not investment advice.